Search Results - "Lin, Ko-Han"

[ 18 F]PSMA-1007 PET/MR as a Precision Biomarker for Early Detection of Biochemical Recurrence in Prostate Cancer at Very Low PSA Levels.

Authors: Lin, Ko-Han Wei, Tzu-Chun Shen, Shu-Huei et al.

Source: Biomarker Insights. May2025, Vol. 20, p1-11. 11p.

The impact of ZTE-based MR attenuation correction compared to CT-AC in ¹⁸F-FBPA PET before boron neutron capture therapy.

Authors: Lo, Yi-Wen Lin, Ko-Han Lee, Chien-Ying et al.

Source: Scientific Reports. 6/17/2024, Vol. 14 Issue 1, p1-9. 9p.

Clinical stage-specific prognostic impact of adequate lymphadenectomy in early-stage lung cancer.

Authors: Liu, Chia Lin, Ko-Han Chen, Hui-Mei et al.

Source: European Journal of Cardio-Thoracic Surgery. Mar2025, Vol. 67 Issue 3, p1-12. 12p.

Comparative biological evaluation of [18F]fluciclovine, [18F]FBPA-Fr, and [18F]FET for boron neutron capture therapy: Preclinical validation and clinical feasibility.

Authors: Chang, Ting-Yu Lin, Ko-Han Lee, Tzu-Yu et al.

Source: Nuclear Medicine & Biology. May2026, Vol. 156, pN.PAG-N.PAG. 1p.

Combined antitumor activity of [¹⁷⁷Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein.

Authors: Tseng, Jin-Ren Hsu, Cheng-Lung Hsieh, Hsin-Hua et al.

Source: EJNMMI Research. 3/4/2026, Vol. 16 Issue 1, p1-11. 11p.

Model-Based Radiation Dose Correction for Yttrium-90 Microsphere Treatment of Liver Tumors With Central Necrosis

Authors: Liu, Ching-Sheng Lin, Ko-Han Lee, Rheun-Chuan et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2011, Vol. 81 Issue 3, p660-668. 9p.

Subjects: Liver tumors, Tumor treatment, Radiation doses, Yttrium-90 radioembolization, Radionuclide imaging, Angiography, Monte Carlo method, Necrosis, Microspheres

Correction: Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein.

Authors: Tseng, Jing-Ren Hsu, Cheng-Lung Hsieh, Hsin-Hua et al.

Source: EJNMMI Research. 4/28/2026, Vol. 16 Issue 1, p1-1. 1p.

SPECT and CT misregistration reduction in [^99mTc]Tc-MAA SPECT/CT for precision liver radioembolization treatment planning.

Authors: Lu, Zhonglin Chen, Gefei Jiang, Han et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2023, Vol. 50 Issue 8, p2319-2330. 12p. 4 Color Photographs, 1 Black and White Photograph, 5 Charts, 2 Graphs.

Boron Neutron Capture Therapy Followed by Image-Guided Intensity-Modulated Radiotherapy for Locally Recurrent Head and Neck Cancer: A Prospective Phase I/II Trial.

Authors: Wang, Ling-Wei Liu, Yen-Wan Hsueh Chu, Pen-Yuan et al.

Source: Cancers. May2023, Vol. 15 Issue 10, p2762. 12p.

Voxel-S-Value based 3D treatment planning methods for Y-90 microspheres radioembolization based on Tc-99m-macroaggregated albumin SPECT/CT.

Authors: Chen, Gefei Lu, Zhonglin Jiang, Han et al.

Source: Scientific Reports. 3/10/2023, Vol. 13 Issue 1, p1-10. 10p.

Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma.

Authors: Lan, Tien-Li Lin, Chun-Fu Lee, Yi-Yen et al.

Source: International Journal of Molecular Sciences. Mar2023, Vol. 24 Issue 5, p4978. 11p.

Latest advances in boron neutron capture therapy for intracranial glioblastoma.

Authors: Chen, Yi-Wei Mu, Pei-Fan Huang, Ting-Yu et al.

Source: Journal of Cancer Research & Practice. Oct-Dec2022, Vol. 9 Issue 4, p129-134. 6p.

Very-Low-Dose Radiation and Clinical Molecular Nuclear Medicine.

Authors: Tsai, Chi-Jung Chang, Kang-Wei Yang, Bang-Hung et al.

Source: Life (2075-1729). Jun2022, Vol. 12 Issue 6, p912. 10p.

Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience.

Authors: Lai, I-Chun Kang, Yu-Mei Wu, Yuan-Hung et al.

Source: Radiotherapy & Oncology. Jan2026, Vol. 214, pN.PAG-N.PAG. 1p.

Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry.

Authors: Wang, Ti-Hao Huang, Pin-I Hu, Yu-Wen et al.

Source: PLoS ONE. 1/2/2018, Vol. 13 Issue 1, p1-14. 14p.

Using salvage Boron Neutron Capture Therapy (BNCT) for recurrent malignant brain tumors in Taiwan.

Authors: Lan, Tien-Li Chou, Fong-In Lin, Ko-Han et al.

Source: Applied Radiation & Isotopes. Jun2020, Vol. 160, pN.PAG-N.PAG. 1p.

Subjects: Boron-neutron capture therapy, Brain tumors, Gliomas, Radiotherapy, Cancer invasiveness

Calculating micro- and macro-scale bone quality parameters from computed tomography images using a parametric physical model and standard bone composition.

Authors: Shih, Cheng-Ting Peng, Shin-Lei Chen, Yi-Wen et al.

Source: Radiation Physics & Chemistry. Nov2024, Vol. 224, pN.PAG-N.PAG. 1p.

Fractionated Boron Neutron Capture Therapy in Locally Recurrent Head and Neck Cancer: A Prospective Phase I/II Trial.

Authors: Wang, Ling-Wei Chen, Yi-Wei Ho, Ching-Yin et al.

Source: International Journal of Radiation Oncology, Biology, Physics. May2016, Vol. 95 Issue 1, p396-403. 8p.

Deep Convolutional Neural Network-Based Positron Emission Tomography Analysis Predicts Esophageal Cancer Outcome.

Authors: Yang, Cheng-Kun Yeh, Joe Chao-Yuan Yu, Wei-Hsiang et al.

Source: Journal of Clinical Medicine. Jun2019, Vol. 8 Issue 6, p844. 1p.

The importance of optimal ROIs delineation for FBPA-PET before BNCT.

Authors: Lo, Yi-Wen Lee, Jia-Cheng Hu, Yong-Sin et al.

Source: Applied Radiation & Isotopes. Sep2020, Vol. 163, pN.PAG-N.PAG. 1p.